HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered

被引:0
|
作者
Graham, Sheila V. [1 ]
机构
[1] Univ Glasgow, Sch Infect & Immun, Coll Med Vet & Life Sci, MRC Univ Glasgow Ctr Virus Res, Glasgow G61 1QH, Scotland
来源
VIRUSES-BASEL | 2024年 / 16卷 / 05期
关键词
Papillomaviruses; RNA binding proteins; RNA processing; epithelial differentiation; life cycle; HUMAN-PAPILLOMAVIRUS TYPE-16; NEGATIVE REGULATORY ELEMENT; LATE GENE-EXPRESSION; CELLULAR SPLICING FACTOR; DNA-DAMAGE RESPONSE; MESSENGER-RNA; L1; PROTEIN; U1; SNRNP; IN-VITRO; POLYADENYLATION ELEMENT;
D O I
10.3390/v16050783
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Papillomavirus gene regulation is largely post-transcriptional due to overlapping open reading frames and the use of alternative polyadenylation and alternative splicing to produce the full suite of viral mRNAs. These processes are controlled by a wide range of cellular RNA binding proteins (RPBs), including constitutive splicing factors and cleavage and polyadenylation machinery, but also factors that regulate these processes, for example, SR and hnRNP proteins. Like cellular RNAs, papillomavirus RNAs have been shown to bind many such proteins. The life cycle of papillomaviruses is intimately linked to differentiation of the epithelial tissues the virus infects. For example, viral late mRNAs and proteins are expressed only in the most differentiated epithelial layers to avoid recognition by the host immune response. Papillomavirus genome replication is linked to the DNA damage response and viral chromatin conformation, processes which also link to RNA processing. Challenges with respect to elucidating how RBPs regulate the viral life cycle include consideration of the orchestrated spatial aspect of viral gene expression in an infected epithelium and the epigenetic nature of the viral episomal genome. This review discusses RBPs that control viral gene expression, and how the connectivity of various nuclear processes might contribute to viral mRNA production.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Halogenation in Fungi: What Do We Know and What Remains to Be Discovered?
    Cochereau, Bastien
    Meslet-Cladiere, Laurence
    Pouchus, Yves Francois
    Grovel, Olivier
    Roullier, Catherine
    MOLECULES, 2022, 27 (10):
  • [2] Polypeptide binding proteins: what remains to be discovered?
    Fischer, Gunter
    Wawra, Stephan
    MOLECULAR MICROBIOLOGY, 2006, 61 (06) : 1388 - 1396
  • [3] WHAT DO WE KNOW ABOUT OFFSPRING AT RISK FOR BIPOLAR DISORDER AND WHAT REMAINS TO BE DISCOVERED
    Nurnberger, John
    McInnis, Melvin
    Fullerton, Janice
    Mitchell, Philip
    Edenberg, Howard
    Hulvershorn, Leslie
    Stapp, Emma
    Wilcox, Holly
    Ghaziuddin, Neera
    Kamali, Masoud
    Roberts, Gloria
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 : 6 - 6
  • [4] Polydomy in ants: what we know, what we think we know, and what remains to be done
    Debout, Gabriel
    Schatz, Bertrand
    Elias, Marianne
    Mckey, Doyle
    BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY, 2007, 90 (02) : 319 - 348
  • [5] What remains to be discovered
    Floyd E. Bloom
    Nature Medicine, 1999, 5 (3) : 258 - 259
  • [6] What remains to be discovered
    Goodstein, DL
    SCIENCE, 1998, 282 (5390) : 886 - 886
  • [7] Drawing in Nonhuman Primates: What We Know and What Remains to Be Investigated
    Martinet, Lison
    Pele, Marie
    JOURNAL OF COMPARATIVE PSYCHOLOGY, 2021, 135 (02) : 176 - 184
  • [8] ZINC FINGER PROTEINS - WHAT WE KNOW AND WHAT WE WOULD LIKE TO KNOW
    ELBARADI, T
    PIELER, T
    MECHANISMS OF DEVELOPMENT, 1991, 35 (03) : 155 - 169
  • [9] Enhancer RNA: What we know and what we can achieve
    Han, Zhenzhen
    Li, Wei
    CELL PROLIFERATION, 2022, 55 (04)
  • [10] Chinese loess and the Asian monsoon: What we know and what remains unknown
    Lu, Huayu
    Wang, Xiaoyong
    Wang, Yao
    Zhang, Xiaojian
    Yi, Shuangwen
    Wang, Xianyan
    Stevens, Thomas
    Kurbanov, Redzhep
    Markovic, Slobodan B.
    QUATERNARY INTERNATIONAL, 2022, 620 : 85 - 97